Alan C. Herman
CIK 1622080 · Chief Scientific Officer · last filed 2017-12-19
Alan C. Herman is a Chief Scientific Officer who has filed 30 SEC Form 4 insider transactions across 1 company since 2014. The most recent filing, for CHRS, was dated Dec 19, 2017. Across all open-market trades the lifetime net is −$5.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $501.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$501.4K
1
30
-$5.87M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CHRS | Chief Scientific Officer | 350,624 | $1.43 | $501.4K | -$5.87M | 30 | 2017-12-19 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-12-19 | CHRS | Grant (A) | +809 | $0 | EDGAR |
| 2017-08-10 | CHRS | Sell (S) | −17,535 | -$263.3K | EDGAR |
| 2017-07-07 | CHRS | Sell (S) | −600 | -$9.0K | EDGAR |
| 2017-06-05 | CHRS | Sell (S) | −11,333 | -$230.3K | EDGAR |
| 2017-05-03 | CHRS | Sell (S) | −11,333 | -$226.6K | EDGAR |
| 2017-04-05 | CHRS | Sell (S) | −11,333 | -$235.0K | EDGAR |
| 2017-03-03 | CHRS | Sell (S) | −11,333 | -$274.2K | EDGAR |
| 2017-02-03 | CHRS | Sell (S) | −11,333 | -$310.2K | EDGAR |
| 2017-01-05 | CHRS | Sell (S) | −11,333 | -$316.7K | EDGAR |
| 2016-12-05 | CHRS | Sell (S) | −11,333 | -$310.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.